Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid and Polymeric Nanoparticles: Successful Strategies for Nose-to-Brain Drug Delivery in the Treatment of Depression and Anxiety Disorders
Margarida Alberto, Ana Cláudia Paiva‐Santos, Francisco Veiga, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2742-2742
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport
Shivani Gandhi, Divyesh H. Shastri, Jigar Shah, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 481-481
Open Access | Times Cited: 18
Preclinical Insights into the Role of Kir4.1 in Chronic Pain and Depression: Mechanisms and Therapeutic Potential
Tingfeng Zha, Xinyi Fang, Jiamin Wan, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 165-165
Open Access | Times Cited: 1
Investigating the Targeting Power to Brain Tissues of Intranasal Rasagiline Mesylate-Loaded Transferosomal In Situ Gel for Efficient Treatment of Parkinson’s Disease
Hala N. ElShagea, Rana R. Makar, Alaa H. Salama, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 533-533
Open Access | Times Cited: 22
Intranasal Bilosomes in Thermosensitive Hydrogel: Advancing Desvenlafaxine Succinate Delivery for Depression Management
Tayseer Elnawawy, Yomna A. Adel, Mahmoud H. Teaima, et al.
Pharmaceutical Development and Technology (2024) Vol. 29, Iss. 7, pp. 663-674
Closed Access | Times Cited: 10
Clinical Insights into MicroRNAs in Depression: Bridging Molecular Discoveries and Therapeutic Potential
Lalit Kaurani
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2866-2866
Open Access | Times Cited: 9
Nanomedicinas: una alternativa terapéutica en desarrollo para el control de las crisis epilépticas
Argelia Rosillo-de la Torre, Laura E. Castellano, David Alcántara-González
eNeurobiología (2025) Vol. 16, Iss. 40
Open Access | Times Cited: 1
Lipid-based nanoparticles via nose-to-brain delivery: a mini review
Yang Xinchen, Jing Tan, Guan Jiaoqiong
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 16
Promoting osteogenesis and bone regeneration employing icariin-loaded nanoplatforms
Mahsa Mohammadzadeh, Masoud Zarei, Hossein Abbasi, et al.
Journal of Biological Engineering (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy
Maria Daniela Ferreira, Joana Duarte, Francisco Veiga, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 678-678
Open Access | Times Cited: 14
Nanoencapsulation of amitriptyline enhances the potency of antidepressant-like effects and exhibits anxiolytic-like effects in Wistar rats
Ramón Eduardo Valadez-Lemus, José L. Góngora‐Alfaro, Juana María Jiménez-Vargas, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316389-e0316389
Open Access
Cyclodextrin-Based Drug Delivery Systems for Depression: Improving Antidepressant Bioavailability and Targeted Central Nervous System Delivery
Renata Maria Văruț, Alin Iulian Silviu Popescu, Simina Găman, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 355-355
Open Access
Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs
Jéssica L. Antunes, Joana Amado, Francisco Veiga, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 998-998
Open Access | Times Cited: 12
Nose to brain delivery of naringin-loaded chitosan nanoparticles for potential use in oxaliplatin-induced chemobrain in rats: impact on oxidative stress, cGAS/STING and HMGB1/RAGE/TLR2/MYD88 inflammatory axes
Diana M. F. Hanna, John Youshia, Sarah Fahmy, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1859-1873
Open Access | Times Cited: 12
Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics
Daniil Sokolov, Neha Sharda, Aindrila Banerjee, et al.
Current Pharmaceutical Design (2023) Vol. 30, Iss. 1, pp. 31-47
Closed Access | Times Cited: 11
Nanoliposomal in situ gel of fluoxetine and embelin as a potent intervention for depression via the intranasal route in CUMS animal model
Asad Ali, Niha Sultana, Ayesha Waheed, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105947-105947
Closed Access | Times Cited: 3
Definition of Design Space for Preparation and Stability of Tramadol Hydrochloride Loaded Nanoparticles Using OFAT Experiments for Infusion in Pain Management
Nuray Yıldırım, Ayhan Savaşer, Özgür Eşi̇m, et al.
Journal of Cluster Science (2024) Vol. 35, Iss. 6, pp. 1797-1807
Open Access | Times Cited: 1
Bacteria associated with glioma: a next wave in cancer treatment
Yiming Meng, Jing Sun, Guirong Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 2
Intranasal thermosensitive hydrogel of agomelatine solid dispersion for better management of depression
Ayman M. Fathi, Rana G. Eissa, Gehan F. Balata, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 88, pp. 104974-104974
Closed Access | Times Cited: 2
Exploring chitosan nanoparticles for enhanced therapy in neurological disorders: a comprehensive review
Safa A Vahab, Kaiprathu Anjali, M. Sabitha, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Surface-engineered Niosomes of Esculin Hydrate for the Management of Depression via Intranasal Route: Optimization, In vitro, Ex vivo and Pharmacokinetic Assessment
Adel Alhowyan, Mohd Imran, Anzarul Haque, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106417-106417
Closed Access
Optimizing nasal drug delivery for peptides, proteins, and small molecules: strategic use of materials and techniques to target the CNS
Vandana Mittal, Khushwant S. Yadav
International Journal of Polymeric Materials (2024), pp. 1-24
Closed Access
Nanocarriers-Assisted Nose-to-Brain Delivery of Levodopa: Current Progress and Prospects
Mariya Dangova, Nadezhda Ivanova, Velichka Andonova
Applied Sciences (2024) Vol. 15, Iss. 1, pp. 331-331
Open Access
Intranasal Drug Delivery: A Non-Invasive Method for improving Neurotherapeutic Delivery
Rashmi G. Khope, Shruti C. Gotmare, Nilakshi N. Dhoble, et al.
Asian Journal of Pharmaceutical Research (2024), pp. 53-61
Closed Access
Advancement in the nose-to-brain drug delivery of FDA-approved drugs for the better management of depression and psychiatric disorders
R. K. Upadhyay, Priyanka Ghosh, Madhuri Desavathu
International Journal of Pharmaceutics (2024), pp. 124866-124866
Closed Access
[Development of a new platform for testing antiviral drugs using coronavirus-infected human nasal mucosa organoids].
Yifei Yu, Jianbo Cao, Rong Liu, et al.
PubMed (2024) Vol. 44, Iss. 11, pp. 2227-2234
Closed Access
Page 1 - Next Page

Scroll to top